Journey Medical Corporation Quarterly report pursuant to Section 13 or 15(d)

INTEREST EXPENSE AND FINANCING FEES

3 Months Ended

Mar. 31, 2024

NOTE 12: INTEREST EXPENSE AND FINANCING FEES

Interest expense and financing fees for the three months ended March 31, 2024 consisted of the following:


	Three-Month Periods Ended March 31,
($’s in thousands)	2024		2023
Interest payments on term loans and LOC	$	486	$	535
Amortization/Accretion		62		33
Imputed interest on acquired intangible assets		—		82
Total Interest expense and financing fees	$	548	$	650